Noter

Diasshow

Disposition

1	Working Classification of Chronic Myeloid Disorders
2
3	De Ph-negative kroniske myeloproliferative sygdomme Erhvervede stamcellesygdomme (klonale myeloprolifeartive sygdomme) Overgangsformer Thrombohæmorrhagiske komplikationer Myelofibrosis Terminalt knoglemarvssvigt/AML
4	De Ph-negative kroniske myeloproliferative sygdomme Behandling Venesektion ( PV) (ht < 0.42 k; < 0.45 m) Cytoreduktion Apurin Acetylsalicylsyre (PV/ET)
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23	Rate of rise in hematocrit in a patient with polycythemia vera who sought treatment of the disease 9 years after the hematocrit began to increase
24
25
26
27
28
29
30
31	Treatment guidelines for PV and ET Nordic MPD study group
32	Idiopathic myelofibrosis ‘…..….this malady of mystery’. Murray Silverstein (1975)
33
34	Potential Cell-Cytokine Interactions in the Pathogenesis of Myelofibrosis with Myeloid Metaplasia
35	Symptoms and Clinical Findings Early Prefibrotic Advanced Idiopathic Myelofibrosis Idiopathic Myelofibrosis Thrombocytosis Hypermetabolic Symptoms Myeloid Metaplasia Bone marrow failure Thrombocytopenia Hypermetabolic Symptoms Myeloid Metaplasia Bone marrow failure
36	Symptoms and Clinical Findings Early Prefibrotic Advanced Idiopathic Myelofibrosis Idiopathic Myelofibrosis Thrombocytosis Hypermetabolic Symptoms Myeloid Metaplasia Bone marrow failure
37	Symptoms and Clinical Findings Thrombocytosis Hypermetabolism Bone Marrow Failure Myeloid Metaplasia
38	Symptoms of Thrombocytosis Early Prefibrotic Idiopathic Myelofibrosis Thrombocytosis - micro/macrocirculatory disturbances /bleeding Leucocytosis No or minimal Anemia No or minimal Splenomegaly
39	Idiopathic Myelofibrosis Early Prefibrotic Myelofibrosis
40
41
42
43
44
45	Pathological Features of Peripheral Blood and Bone Marrow in Myelofibrosis with Myeloid Metaplasia
46
47
48
49	The differential diagnosis of massive splenomegaly, operationally defined as a palpable spleen that extends below the transumbilical line Myelofibrosis with myeloid metaplasia (MMM) Chronic myeloid leukemia Malignant lymphoma Hairy cell leukemia Hyperreactive malarial splenomegaly Kala-azar (visceral leishmaniasis) Gaucher disease Splenic cystic lymphangiomatosis Systemic lupus erythematosus, Sarcoidosis
50	The differential diagnosis of massive splenomegaly, operationally defined as a palpable spleen that extends below the transumbilical line Myelofibrosis with myeloid metaplasia (MMM) Chronic myeloid leukemia Malignant lymphoma Hairy cell leukemia Hyperreactive malarial splenomegaly Kala-azar (visceral leishmaniasis) Gaucher disease Splenic cystic lymphangiomatosis Systemic lupus erythematosus, Sarcoidosis
51	Modern Treatment of Myelofibrosis With Myeloid Metaplasia (MMM)
52
53	The Spleen in Myelofibrosis With Myeloid Metaplasia (MMM) In MMM splenomegaly is secondary to extramedullary hematopoiesis
54	Symptoms of Progressive Splenomegaly in Myelofibrosis with Myeloid Metaplasia Mechanical discomfort Early satiety Episodes of severe left upper quadrant pain from splenic infarcts Profound cachexia Increased red blood cell transfusion requirement Thrombocytopenia Complications of portal hypertension
55	Tefferi A, Mesa RA, Nagorney DM, Schroeder G, Silverstein MN. Splenectomy in myelofibrosis with myeloid metaplasia: a single-institution experience with 223 patients. Blood. 2000;95:2226-2233.
56	Prognosis in Myelofibrosis With Myeloid Metaplasia (MMM) In MMM
57	The Lille Scoring System (adverse prognostic factors Hb<10; WCC<4 >30